DRUG ENFORCEMENT ADMINISTRATION related term(s) Department of Justice

Amendments

Depts. of Commerce, Justice, Agriculture, Interior, Transportation, HUD, and VA, FDA, EPA, science, and military construction: making appropriations (H.R. 3055), S5951, S5978–S6046 [22OC], S6098–S6133 [23OC], S6165–S6175 [24OC], S6183, S6185, S6186, S6194–S6204 [28OC], S6248–S6254 [29OC], S6306 [30OC], S6311–S6315, S6321 [31OC], S6722, S6723 [20NO], S6734 [21NO], H4804, H4877, H4878, H4879, H4880, H4883, H4884, H4885, H4886, H4888, H4889, H4890, H4891, H4892, H4893, H4894, H4895, H4896 [19JN], H4930, H4931, H4932, H4933, H4934, H4935, H4936, H4937, H4938, H4939 [20JN], H8972, H9035 [19NO]

——— making appropriations (H.R. 3055), consideration (H. Res. 445), H4787 [19JN]

Bills and resolutions

Capitol Building and Grounds: authorize use of Hart Senate Office Building atrium for DEA National Drug Take Back Day event (see S. Res. 158), S2387 [10AP]

——— authorize use of Philip A. Hart Senate Office Building atrium for DEA National Prescription Drug Take Back Day (see S. Res. 359), S5841 [16OC]

Crime: provide information on best practices and strategies for responding in the event of a robbery of a pharmacy (see H.R. 4505), H8052 [26SE]

Dept. of Justice: make procurement quotas for opioid analgesics publicly available to disclose applications requesting active ingredients and amount of opioids alloted to be produced by manufacturers (see S. 1366), S2742 [8MY] (see H.R. 2582), H3500 [8MY]

——— provide grants for drug disposal sites (see H.R. 3171), H4387 [10JN]

——— require registration of tableting or encapsulating machines to assist law enforcement in identifying counterfeit pill makers (see S. 989), S2189 [2AP] (see H.R. 2020), H2985 [2AP]

Depts. of Commerce, Justice, Agriculture, Interior, Transportation, HUD, and VA, FDA, EPA, science, and military construction: making appropriations (H.R. 3055), consideration (see H. Res. 445), H4769 [18JN]

——— making appropriations (H.R. 3055), consideration of Senate amendment (see H. Res. 708), H8957 [18NO]

——— making appropriations (H.R. 3055), correction in enrollment (see H. Con. Res. 75), H9057 [19NO]

Drugs: amend certain regulations so that practitioners may not administer more than 3 days of medication to a person at one time when administering narcotics in order to relieve acute withdrawal symptoms (see H.R. 2281), H3255 [10AP]

——— authorize debarment of certain controlled substances registrants (see H.R. 4806), H8455 [23OC]

——— clarify definition of ‘‘imminent danger to the public health or safety’’ to restore authority to suspend a pharmaceutical distributor’s license under certain circumstances (see H.R. 4563), H8080 [27SE]

——— clarify how controlled substance analogues that are imported or offered for import are to be regulated (see S. 2764), S6333 [31OC] (see H.R. 4963), H8718 [31OC]

——— convene a task force to recommend the most effective program to share data and implement real-time drug diversion prevention (see S. 2686), S6092 [23OC] (see H.R. 4814), H8455 [23OC]

——— decriminalize, expunge prior convictions, tax products to create programs for those adversely affected by War on Drugs, and provide assistance and collect data on small businesses relative to marijuana (see S. 2227), S5012 [23JY] (see H.R. 3884), H7240 [23JY]

——— decriminalize marijuana, use tax revenues to assist certain small businesses, research effects on driving and health, restrict advertising to protect children, and expunge certain marijuana-related convictions (see S. 1552), S2962 [20MY] (see H.R. 2843), H4009 [20MY]

——— decriminalize marijuana at the Federal level and leave States the power to regulate marijuana similar to the power to regulate alcohol (see H.R. 420), H358 [9JA]

——— deem drugs or other substances that act as mu opioid receptor agonists to be in Schedule I of the Controlled Substances Act, designating they have high potential for abuse and have no medical use (see H.R. 2580), H3500 [8MY]

——— develop national cannabis research agenda, collect data on cannabis use and impacts on health outcomes, change controlled substance classification of cannabis, and streamline DEA approval of research (see S. 2400), S5248 [31JY] (see H.R. 4322), H7705 [12SE]

——— eliminate separate registration requirement for dispensing narcotic drugs categorized in schedules with lower potential for abuse that are intended for maintenance or detoxification treatment (see S. 2074), S4773 [10JY] (see H.R. 2482), H3439 [2MY]

——— extend temporary scheduling order listing fentanyl-related substances under schedule I of the Controlled Substances Act, designating they have high potential for abuse and have no medical use (see H.R. 5233), H9168 [21NO]

——— improve medical research on marijuana by simplifying registration process to conduct research, facilitating access for such research, and allowing private manufacture and distribution for research purposes (see H.R. 3797), H5998 [17JY]

——— include fentanyl-related substances under schedule I of the Controlled Substances Act, designating they have high potential for abuse and have no medical use (see S. 1622), S3059 [22MY] (see S. 2701), S6155 [24OC] (see S. 3148), S7208 [19DE] (see H.R. 2935), H4119 [22MY] (see H.R. 5421), H10257 [12DE]

——— increase number of cannabis manufacturers registered under Controlled Substances Act for legitimate research purposes and allow VA health care providers to recommend federally-approved cannabis clinical trials (see H.R. 601), H674 [16JA]

——— prohibit knowing possession of a pill press mold with intent to manufacture a counterfeit substance in schedule I or II in a capsule, tablet, and other form intended for distribution (see S. 2573), S5748 [26SE] (see H.R. 4510), H8053 [26SE]

——— provide for enhanced penalties for certain offenses relative to controlled substances containing fentanyl (see H.R. 1655), H2614 [8MR]

——— provide for modification, transfer, and termination of a registration to manufacture, distribute, or dispense controlled substances or list I chemicals (see H.R. 4812), H8455 [23OC]

——— regulate selective androgen receptor modulators in the same manner as anabolic steroids (see S. 2895), S6669 [19NO]

——— report certain information on distribution of opioids to assist in identifying suspicious orders and hold manufacturers and distributors accountable who fail to report and stop suspicious orders (see S. 3070), S7113 [17DE]

——— reschedule marijuana under the Controlled Substances Act (see H.R. 4323), H7705 [12SE]

——— restore ability to target pharmaceutical companies distributing opioids in certain communities by implementing a probable cause standard for intervention and striking the corrective action plan option (see S. 424), S1133 [7FE]

——— streamline, coordinate and expand research and foster increased communication between doctors and patients relative to cannabidiol and other marijuana components and their medical benefits (see S. 2032), S4628 [27JN]

FDA: hold pharmaceutical companies accountable for dubious marketing and distribution of opioid products and for their role in creating and exacerbating the opioid epidemic (see S. 1584), S3005 [21MY] (see H.R. 2917), H4118 [22MY]

Health care facilities: allow community addiction treatment facilities and community mental health facilities to register to dispense controlled substances through telemedicine (see S. 2244), S5062 [24JY] (see H.R. 4131), H7481 [30JY]

Health care professionals: require to certify they will not prescribe more than a seven-day supply of opioids as treatment for acute pain or provide refills as part of their registration to prescribe opioids (see S. 724), S1734 [7MR] (see H.R. 1614), H2583 [7MR]

Languages: provide a cash award to employees with foreign language skills (see H.R. 2307), H3263 [12AP]

Red Ribbon Week: support goals and ideals (see S. Res. 366), S5922 [21OC]

Science, Depts. of Justice and Commerce, and related agencies: making appropriations (see S. 2584), S5748 [26SE] (see H.R. 3055), H4215 [3JN]

U.S. Intelligence Professionals Day: designate (see S. Res. 286), S5108 [25JY]

Cloture motions

Depts. of Commerce, Justice, Agriculture, Interior, Transportation, HUD, and VA, FDA, EPA, science, and military construction: making appropriations (H.R. 3055), S6187 [28OC], S6271 [30OC], S6735 [21NO]

——— making appropriations (H.R. 3055), motion to proceed, S5881 [17OC], S5946 [22OC]

Letters

Secure and Fair Enforcement (SAFE) Banking Act: several former Office of National Drug Control Policy and DEA officials, H7966 [25SE]

Lists

Senate staff who worked on H.R. 3055, Depts. of Commerce, Justice, Agriculture, Interior, Transportation, HUD, and VA, FDA, EPA, science, and military construction appropriations, S6322 [31OC]

Motions

Depts. of Commerce, Justice, Agriculture, Interior, Transportation, HUD, and VA, FDA, EPA, science, and military construction: making appropriations (H.R. 3055), S5880 [17OC], S6734, S6735 [21NO], H5102 [25JN], H9035 [19NO]

Remarks in House

Dept. of Justice: Comprehensive Opioid Abuse Program funding, H4936 [20JN]

Depts. of Commerce, Justice, Agriculture, Interior, Transportation, HUD, and VA, FDA, EPA, science, and military construction: making appropriations (H.R. 3055), H4670 [13JN], H4797–H4896 [19JN], H4928, H4929–H4997 [20JN], H5011–H5022 [21JN], H5047–H5072 [24JN], H5090, H5100–H5104 [25JN], E811 [20JN], E826 [24JN], E832, E835, E836 [25JN], E860 [27JN], E870 [2JY]

——— making appropriations (H.R. 3055), consideration (H. Res. 445), H4779–H4789 [19JN]

——— making appropriations (H.R. 3055), consideration of Senate amendment (H. Res. 708), H8967–H8971 [19NO]

——— making appropriations (H.R. 3055), correction in enrollment (H. Con. Res. 75), H9041 [19NO]

——— making appropriations (H.R. 3055), Senate amendment, H8966, H8972–H9041 [19NO], H9156 [21NO], E1483 [20NO]

Drugs: address prescription opioid and heroin abuse, H548 [15JA]

——— clarify how synthetic drugs known as analogues are to be regulated, H2618 [11MR]

——— decriminalize, expunge prior convictions, tax products to create programs for those adversely affected by War on Drugs, and provide assistance and collect data on small businesses relative to marijuana (H.R. 3884), H7969, H7971 [25SE]

——— eliminate separate registration requirement for dispensing narcotic drugs categorized in schedules with lower potential for abuse that are intended for maintenance or detoxification treatment (H.R. 2482), H3508 [9MY], H7998 [26SE]

——— reschedule marijuana under the Controlled Substances Act, H7965, H7969, H7970 [25SE]

National Prescription Drug Take Back Day: observance, H3296 [29AP]

Office of the Director of National Intelligence: assess drug trafficking and human trafficking and smuggling in Mexico and Northern Triangle countries of El Salvador, Guatemala, and Honduras, H5889, H5890 [16JY]

Science, Depts. of Justice and Commerce, and related agencies: across-the-board funding reduction for non-defense activities, H4893 [19JN]

——— making appropriations, H184 [3JA], H1151, H1152 [23JA], H10380, H10383 [17DE]

Remarks in Senate

Capitol Building and Grounds: authorize use of atrium in the Philip A. Hart Senate Office Building for National Prescription Drug Take Back Day, a semiannual event for the DEA (S. Res. 359), S5853 [16OC]

——— authorize use of Hart Senate Office Building atrium for DEA National Drug Take Back Day event (S. Res. 158), S2392 [10AP]

Dept. of Defense: analyze deaths of servicemembers during training exercises and offer recommendations to prevent or minimize accidents during future exercises, S4562 [26JN]

Depts. of Commerce, Justice, Agriculture, Interior, Transportation, HUD, and VA, FDA, EPA, science, and military construction: across-the-board funding reduction, S6184, S6186 [28OC]

——— making appropriations (H.R. 3055), S4739 [9JY], S4744 [10JY], S5913 [21OC], S5951–S5953, S5959 [22OC], S6057–S6060, S6065 [23OC], S6179, S6180, S6183–S6187 [28OC], S6208–S6216, S6218, S6221–S6223, S6227, S6232, S6233 [29OC], S6263, S6284 [30OC], S6315, S6319–S6323, S6327, S6359 [31OC], S6386 [5NO], S6503, S6504 [12NO]

——— making appropriations (H.R. 3055), correction in enrollment (H. Con. Res. 75), S6736 [21NO]

——— making appropriations (H.R. 3055), House amendment, S6631, S6641 [19NO], S6682, S6696, S6703 [20NO], S6730–S6736 [21NO]

——— making appropriations (H.R. 3055), motion to proceed, S5880 [17OC], S5911 [21OC], S5931, S5933, S5944–S5947, S5949–S5951 [22OC]

——— making appropriations (H.R. 3055), unanimous-consent agreement, S6146 [24OC], S6293, S6294 [30OC]

Drugs: include all controlled substance analogues under schedule I of the Controlled Substances Act, designating they have high potential for abuse and have no medical use, regardless if intended for human consumption, S6279 [30OC]

——— include fentanyl-related substances under schedule I of the Controlled Substances Act, designating they have high potential for abuse and have no medical use (S. 2701), S6276 [30OC]

——— include fentanyl-related substances under schedule I of the Controlled Substances Act, designating they have high potential for abuse and have no medical use (S. 3148), S7236 [19DE]

——— report certain information on distribution of opioids to assist in identifying suspicious orders and hold manufacturers and distributors accountable who fail to report and stop suspicious orders (S. 3070), S7116 [17DE]

——— streamline, coordinate and expand research and foster increased communication between doctors and patients relative to cannabidiol and other marijuana components and their medical benefits (S. 2032), S4633 [27JN]

FDA: hold pharmaceutical companies accountable for illegal marketing and distribution of opioid products and for their role in creating and exacerbating the opioid epidemic, S4883–S4885 [17JY]

Health care facilities: allow community addiction treatment facilities and community mental health facilities to register to dispense controlled substances through telemedicine (S. 2244), S6280 [30OC]

U.S. Intelligence Professionals Day: designate (S. Res. 286), S5118 [25JY]

Reports filed

Consideration of H.R. 3055, Depts. of Commerce, Justice, Agriculture, Interior, Transportation, HUD, and VA, FDA, EPA, Science, and Military Construction Appropriations: Committee on Rules (House) (H. Res. 445) (H. Rept. 116–119), H4769 [18JN]

Science, Depts. of Justice and Commerce, and Related Agencies Appropriations: Committee on Appropriations (House) (H.R. 3055) (H. Rept. 116–101), H4215 [3JN]

——— Committee on Appropriations (Senate) (S. 2584) (S. Rept. 116–127), S5747 [26SE]

Tables

Top opioid distributors and manufacturers 2006 through 2012, S4884 [17JY]

Texts of

H. Res. 445, consideration of H.R. 3055, Depts. of Commerce, Justice, Agriculture, Interior, Transportation, HUD, and VA, FDA, EPA, science, and military construction appropriations, H4779 [19JN]

H.R. 3055, Depts. of Commerce, Justice, Agriculture, Interior, Transportation, HUD, and VA, FDA, EPA, science, and military construction appropriations, H4804–H4877 [19JN]

S. 1552, Marijuana Freedom and Opportunity Act, S2971 [20MY]

S. 2400, Expanding Cannabis Research and Information Act, S5253 [31JY]

S. 3148, Stopping Overdoses of Fentanyl Analogues Act, S7212 [19DE]

S. Res. 158, use of Hart Senate Office Building atrium for DEA National Drug Take Back Day event, S2391 [10AP]

S. Res. 286, U.S. Intelligence Professionals Day, S5113 [25JY]

S. Res. 359, use of Philip A. Hart Senate Office Building atrium for DEA National Prescription Drug Take Back Day, S5851 [16OC]

S. Res. 366, support goals and ideals of Red Ribbon Week, S5926 [21OC]